Betsy Wernli, M.D., president, Forefront Dermatology, offers insights into pros and cons of various practice model options.
Summer AAD 2019
The narrative about food, diet and atopic dermatitis recently changed significantly after publication of the Learning Early About Peanut study, says Peter Lio, M.D. Diet matters, and he discusses in what ways.
Patients on powerful immunocompromising agents might be predisposed to infections; however the potential association between biologic agents and increased risk isn’t necessarily universal, Whitney High, M.D., reported during the summer meeting of the American Academy of Dermatology.
There have been several shifts over time around beliefs in the association between diet and acne. Linda Stein Gold, M.D., discussed the recommendations of current guidelines at the summer meeting of the American Academy of Dermatology.
Kimberly S. Salkey, M.D., shares answers to some of the most common questions she encounters from patients about OTC hair loss treatments.
GEP testing could improve staging accuracy and help streamline disease management, but more research is needed to determine if a high-risk GEP classification is associated with improved response to newer systemic therapies.
Check back for highlights from key speakers at this year's Summer AAD meeting in New York City.